Gene Therapy for Ovarian Cancer - A Pipeline Analysis Report

Published: Feb 2018
Pages: 73
SKU: IRTNTR20288

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version!

Gene therapy for ovarian cancer industry insights

Technavio’s market research analysts have predicted that with the emergence of gene therapy as an approach for the treatment of ovarian cancer, the global ovarian cancer market will witness considerable growth in the coming years. With the potential to cure ovarian cancer by replacing faulty genes with normal ones, replacement gene therapy will gain prominence during the next few years.

Get A Free Sample

According to gene therapy for ovarian cancer industry analysis, companies are focusing on evaluating pipeline molecules for recurrent ovarian epithelial cancer and platinum-resistant ovarian cancer. Our market research analysts have also identified that most of the gene therapy candidates in the pipeline are being developed for platinum-resistant ovarian cancer.

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

PART 05: MAJOR REGULATORY AUTHORITIES

US
Europe
China

PART 06: PIPELINE LANDSCAPE

PART 07: COMPARATIVE ANALYSIS

Discovery stage molecules
Pre-clinical stage molecules
Inactive and discontinued molecules

PART 08: INDICATION ANALYSIS

PART 09: THERAPEUTIC ASSESSMENT (THERAPY BASED)

PART 10: THERAPEUTIC ASSESSMENT (ROA BASED)

PART 11: THERAPEUTIC ASSESSMENT BY TARGET

PART 12: KEY COMPANIES

Active companies: Category and parameters

PART 13: APPENDIX

List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES